• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对腹主动脉瘤患者皮肤中一种假定的交联氨基酸(3-脱氧吡啶啉)的进一步研究。

Further studies of a putative cross-linking amino acid (3-deoxypyridinoline) in skin from patients with abdominal aortic aneurysms.

作者信息

Tilson M D

出版信息

Surgery. 1985 Nov;98(5):888-91.

PMID:4060067
Abstract

A recent report claimed that an amine in human skin (believed to be pyridinoline) was deficient in specimens from patients with abdominal aortic aneurysms (AAA). Further studies suggest that this work was erroneous in two respects. First, the amine has been isolated and partially characterized; the major component of the peak of interest is a deoxyanalogue of pyridinoline. It may be a collagen cross-link of some biologic importance, because it is not detectable in skin from a patient with Marfan's syndrome. Second, further studies in an additional 19 patients with AAA and an additional 13 controls suggest that this amine is abnormally abundant in skin from patients with AAA. This difference cannot be accounted for by any potential source of artifact that has been traceable. The effects of age, diabetes, sex, race, site of biopsy, and source of specimen (autopsy versus surgery) have been studied; none of these variables can account for the high ratio of pyridinolines to hydroxylysine found in skin from patients with AAA.

摘要

最近一份报告称,人体皮肤中的一种胺(据信是吡啶啉)在腹主动脉瘤(AAA)患者的样本中含量不足。进一步的研究表明,这项研究在两个方面存在错误。首先,这种胺已被分离并进行了部分表征;感兴趣的峰的主要成分是吡啶啉的脱氧类似物。它可能是一种具有一定生物学重要性的胶原蛋白交联物,因为在马凡氏综合征患者的皮肤中检测不到它。其次,对另外19例AAA患者和13例对照进行的进一步研究表明,这种胺在AAA患者的皮肤中异常丰富。这种差异无法用任何可追溯的潜在假象来源来解释。已经研究了年龄、糖尿病、性别、种族、活检部位和样本来源(尸检与手术)的影响;这些变量都无法解释AAA患者皮肤中吡啶啉与羟赖氨酸的高比例。

相似文献

1
Further studies of a putative cross-linking amino acid (3-deoxypyridinoline) in skin from patients with abdominal aortic aneurysms.对腹主动脉瘤患者皮肤中一种假定的交联氨基酸(3-脱氧吡啶啉)的进一步研究。
Surgery. 1985 Nov;98(5):888-91.
2
[Surgery of abdominal aorta with horseshoe kidney].马蹄肾腹主动脉手术
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):36-44.
3
Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.从患有Ⅵ型埃勒斯-当洛综合征患者培养的皮肤成纤维细胞中胶原蛋白交联的异常形成。
Proc Assoc Am Physicians. 1997 Jan;109(1):33-41.
4
Deficiencies of copper and a compound with ion-exchange characteristics of pyridinoline in skin from patients with abdominal aortic aneurysms.腹主动脉瘤患者皮肤中铜及具有吡啶啉离子交换特性的化合物缺乏。
Surgery. 1983 Aug;94(2):134-41.
5
Collagen cross-linking by pyridinoline occurs in non-reversible skin fibrosis.由吡啶啉介导的胶原蛋白交联发生在不可逆的皮肤纤维化过程中。
Cell Mol Biol (Noisy-le-grand). 1993 Nov;39(7):723-7.
6
[Assay of cross-linking molecules of collagen (pyridinolines) in the study of the degradation of bone tissue and articular cartilage].[在骨组织和关节软骨降解研究中胶原蛋白交联分子(吡啶啉)的测定]
Pathol Biol (Paris). 1993 Dec;41(10):951-61.
7
Consequences of diabetes mellitus or liver cirrhosis on total collagen in human skin biopsies.糖尿病或肝硬化对人体皮肤活检中总胶原蛋白的影响。
Biomed Pharmacother. 1984;38(2):110-4.
8
Reduced aortic wall stress in diabetes mellitus.糖尿病患者主动脉壁应力降低。
Eur J Vasc Endovasc Surg. 2007 May;33(5):592-8. doi: 10.1016/j.ejvs.2006.11.011. Epub 2006 Dec 11.
9
The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan's syndrome.马凡综合征中阻塞性睡眠呼吸暂停的患病率及其与主动脉扩张的关联。
Thorax. 2009 Feb;64(2):162-6. doi: 10.1136/thx.2008.102756. Epub 2008 Oct 13.
10
Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms.胸主动脉瘤和腹主动脉瘤患者之间动脉粥样硬化特征的差异。
Am J Cardiol. 2008 Mar 1;101(5):696-9. doi: 10.1016/j.amjcard.2007.10.039. Epub 2007 Dec 21.

引用本文的文献

1
Aortic aneurysms: an immune disease with a strong genetic component.主动脉瘤:一种具有强大遗传成分的免疫疾病。
Circulation. 2008 Jan 15;117(2):242-52. doi: 10.1161/CIRCULATIONAHA.107.690982.